Can Yücel Karabay, Hakan Taşolar, Ayşegül Ülgen Kunak, Murat Çap, Mehmet Ali Astarcıoğlu, Taner Şen, Mehmet Kaplan, Muharrem Said Coşgun, Fahriye Vatansever Ağca, Uğur Arslan, Gönül Açıksarı, Fahri Er, Kadir Uğur Mert, Öner Özdoğan, Serhat Çalışkan, Ercan Akşit, Ahmet Seyda Yılmaz, Emrah Aksakal, Zeki Şimşek, Süleyman Çağan Efe, Gülşah Aktüre, Ferit Böyük, Özcan Başaran, Mehmet Ballı, Ahmet Oğuz Aslan, Gamze Babur Güler, Ulaankhuu Batgerel, Flora Özkalaycı, Bedri Caner Kaya, Batur Gönenç Kanar, Muammer Karakayalı, Emrah Erdoğan, Gürkan İş, Sedat Kalkan, Sinan Demirel, Uğur Aksu, Ümit Güray, Hasan Aydın Baş, Murat Gök, Mehmet Fatih Yılmaz, Barış Şimşek, Zeynep Kolak, Melih Öz, Utku Uluköksal, Hüseyin Emre Kuloğlu, Gizem Çabuk, Fatma Köksal, Ahmet Cem Nizam, Rabia Çoldur, Faysal Şaylık, İbrahim Halil Tanboğa
BACKGROUND: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide and is associated with an increased risk of thromboembolism, ischemic stroke, impaired quality of life, and mortality. The latest research that shows the prevalence and incidence of AF patients in Türkiye was the Turkish Adults' Heart Disease and Risk Factors study, which included 3,450 patients and collected data until 2006/07.The Turkish Real Life Atrial Fibrillation in Clinical Practice (TRAFFIC) study is planned to present current prevalence data, reveal the reflection of new treatment and risk approaches in our country, and develop new prediction models in terms of outcomes...
January 7, 2024: Anatolian Journal of Cardiology